TickerFacts.

EUDA Health Holdings Ltd (EUDA): Cost of Revenue

Annual figures by period end, from SEC filings.

$3.83M
Year ended 2025-12-31
+9.8%
3-year compound annual growth
2021-12-31: $3.31M2022-12-31: $2.89M2023-12-31: $2.86M2024-12-31: $3.25M2025-12-31: $3.83M$3.83M
2021-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$3.83M+17.8%2026-04-28, From 2025-01-01
2024-12-31$3.25M+13.4%2026-04-28, From 2024-01-01
2023-12-31$2.86M-1.0%2026-04-28, From 2023-01-01
2022-12-31$2.89M-12.5%2025-09-24, From 2022-01-01
2021-12-31$3.31Mn/a2024-05-09, From 2021-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
EUDA Health Holdings Ltd (EUDA)2025-12-31$3.83M+17.8%
Vsee Health, Inc. (VSEE)2025-12-31$7.26M+123.9%
Longduoduo Co Ltd (LDDD)2026-06-30$17.0K-81.4%
Agape ATP Corp (ATPC)2025-12-31$686.0K+21.7%
Strata Critical Medical, Inc. (SRTA)2025-12-31$156.01M+33.1%
Omada Health, Inc. (OMDA)2025-12-31$89.27M+33.4%
GeneDx Holdings Corp. (WGS)2025-12-31$129.37M+16.5%

Compare EUDA, VSEE, LDDD, ATPC side by side · Screen every company in Services-Health Services ↗